Stacy Price
Chief Tech/Sci/R&D Officer at INVIVYD, INC.
Net worth: - $ as of 30/04/2024
Stacy Price active positions
Companies | Position | Start | End |
---|---|---|---|
INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 01/03/2023 | - |
Career history of Stacy Price
Former positions of Stacy Price
Companies | Position | Start | End |
---|---|---|---|
AKOUOS | Chief Tech/Sci/R&D Officer | 01/11/2021 | - |
ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Stacy Price
Tufts University | Graduate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ALAUNOS THERAPEUTICS, INC. | Health Technology |
INVIVYD, INC. | Health Technology |
Private companies | 1 |
---|---|
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Stacy Price
- Experience